|
Quality Id |
Measure Name |
High Priority |
Measure Type |
Measure Description |
|
001 |
Diabetes: Hemoglobin A1c (HbA1c)
Poor Control (>9%) |
Yes |
Intermediate Outcome |
Percentage of patients 18-75 years
of age with diabetes who had hemoglobin A1c > 9.0% during the measurement
period |
|
005 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left
Ventricular Systolic Dysfunction (LVSD) |
No |
Process |
Percentage of patients aged 18
years and older with a diagnosis of heart failure (HF) with a current or
prior left ventricular ejection fraction (LVEF) < 40% who were prescribed
ACE inhibitor or ARB therapy either within a 12 month period when seen in the
outpatient setting OR at each hospital discharge |
|
006 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No |
Process |
Percentage of patients aged 18
years and older with a diagnosis of coronary artery disease (CAD) seen within
a 12 month period who were prescribed aspirin or clopidogrel |
|
007 |
Coronary Artery Disease (CAD):
Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular
Systolic Dysfunction (LVEF < 40%) |
No |
Process |
Percentage of patients aged 18
years and older with a diagnosis of coronary artery disease seen within a
12-month period who also have a prior MI OR a current or prior LVEF <40%
who were prescribed beta-blocker therapy |
|
008 |
Heart Failure (HF): Beta-Blocker
Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No |
Process |
Percentage of patients aged 18
years and older with a diagnosis of heart failure (HF) with a current or
prior left ventricular ejection fraction (LVEF) < 40% who were prescribed
beta-blocker therapy either within a 12-month period when seen in the outpatient
setting OR at each hospital discharge |
|
024 |
Communication with the Physician or
Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged
50 Years and Older |
Yes |
Process |
Percentage of patients aged 50
years and older treated for a fracture with documentation of communication,
between the physician treating the fracture and the physician or other
clinician managing the patient’s on-going care, that a fracture occurred and
that the patient was or should be considered for osteoporosis treatment or
testing. This measure is reported by the physician who treats the fracture
and who therefore is held accountable for the communication |
|
039 |
Screening for Osteoporosis for
Women Aged 65-85 Years of Age |
No |
Process |
Percentage of female patients aged
65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis |
|
047 |
Care Plan |
Yes |
Process |
Percentage of patients aged 65
years and older who have an advance care plan or surrogate decision maker
documented in the medical record that an advance care plan was discussed but
the patient did not wish or was not able to name a surrogate decision maker
or provide an advance care plan |
|
048 |
Urinary Incontinence: Assessment of
Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older |
No |
Process |
Percentage of female patients aged
65 years and older who were assessed for the presence or absence of urinary
incontinence within 12 months |
|
050 |
Urinary Incontinence: Plan of Care
for Urinary Incontinence in Women Aged 65 Years and Older |
Yes |
Process |
Percentage of female patients aged
65 years and older with a diagnosis of urinary incontinence with a documented
plan of care for urinary incontinence at least once within 12 months |
|
065 |
Appropriate Treatment for Children
with Upper Respiratory Infection (URI) |
No |
Process |
Percentage of children 3 months-18
years of age who were diagnosed with upper respiratory infection (URI) and
were not dispensed an antibiotic prescription on or three days after the
episode |
|
066 |
Appropriate Testing for Children
with Pharyngitis |
No |
Process |
Percentage of children 3-18 years
of age who were diagnosed with pharyngitis, ordered
an antibiotic and received a group A streptococcus (strep) test for the
episode |
|
091 |
Acute Otitis
Externa (AOE): Topical Therapy |
No |
Process |
Percentage of patients aged 2 years
and older with a diagnosis of AOE who were prescribed topical preparations |
|
093 |
Acute Otitis
Externa (AOE): Systemic Antimicrobial Therapy –
Avoidance of Inappropriate Use |
No |
Process |
Percentage of patients aged 2 years
and older with a diagnosis of AOE who were not prescribed systemic
antimicrobial therapy |
|
109 |
Osteoarthritis (OA): Function and
Pain Assessment |
Yes |
Process |
Percentage of patient visits for
patients aged 21 years and older with a diagnosis of osteoarthritis (OA) with
assessment for function and pain |
|
110 |
Preventive Care and Screening:
Influenza Immunization |
No |
Process |
Percentage of patients aged 6 months
and older seen for a visit between October 1 and March 31 who received an
influenza immunization OR who reported previous receipt of an influenza
immunization |
|
111 |
Pneumococcal Vaccination Status for
Older Adults |
No |
Process |
Percentage of patients 65 years of
age and older who have ever received a pneumococcal vaccine |
|
112 |
Breast Cancer Screening |
No |
Process |
Percentage of women 50-74 years of
age who had a mammogram to screen for breast cancer |
|
113 |
Colorectal Cancer Screening |
No |
Process |
Percentage of adults 50-75 years of
age who had appropriate screening for colorectal cancer |
|
116 |
Avoidance of Antibiotic Treatment
in Adults With Acute Bronchitis |
No |
Process |
The percentage of adults 18–64
years of age with a diagnosis of acute bronchitis who were not prescribed or
dispensed an antibiotic prescription |
|
117 |
Diabetes: Eye Exam |
No |
Process |
Percentage of patients 18-75 years
of age with diabetes who had a retinal or dilated eye exam by an eye care
professional during the measurement period or a negative retinal exam (no
evidence of retinopathy) in the 12 months prior to the measurement period |
|
119 |
Diabetes: Medical Attention for
Nephropathy |
No |
Process |
The percentage of patients 18-75
years of age with diabetes who had a nephropathy screening test or evidence
of nephropathy during the measurement period |
|
126 |
Diabetes Mellitus: Diabetic Foot
and Ankle Care, Peripheral Neuropathy – Neurological Evaluation |
No |
Process |
Percentage of patients aged 18
years and older with a diagnosis of diabetes mellitus who had a neurological
examination of their lower extremities within 12 months |
|
128 |
Preventive Care and Screening: Body
Mass Index (BMI) Screening and Follow-Up Plan |
No |
Process |
Percentage of patients aged 18
years and older with a BMI documented during the current encounter or during
the previous twelve months AND with a BMI outside of normal parameters, a
follow-up plan is documented during the encounter or during the previous twelve
months of the current encounter |
|
130 |
Documentation of Current
Medications in the Medical Record |
Yes |
Process |
Percentage of visits for patients
aged 18 years and older for which the eligible professional or eligible
clinician attests to documenting a list of current medications using all
immediate resources available on the date of the encounter. This list must include
ALL known prescriptions, over-the-counters, herbals, and
vitamin/mineral/dietary (nutritional) supplements AND must contain the
medications’ name, dosage, frequency and route of administration |